Current progress in microbiome biomarker discovery
The human microbiome: defining microbiome biomarkers The microbiome, home to trillions of bacteria, fungi, and viruses, is comprised of 10-fold more cells than the human body.1 Potentially impacting the health and wellbeing of the host, these microbes directly interact with host cells and metabolic pathways. Researchers profiling the microbiome have
Mouse microbiome platform for translational mouse model research: MetaGene Mouse
With over 99% mouse gene homologs in humans, mouse models provide valuable insights into the pathogenesis and treatment of human diseases like cancer, diabetes and obesity.
Multiomics in microbiome studies: Enabling research on new therapies and treatments
If you’ve attended recent conferences focused on life sciences, you might have heard the phrase “multiomics brings together all the puzzle pieces,” or something similar. More research has begun to adopt this new approach of bringing together multiple “omes” in a study to see a better picture than if you
Highlights from the Crohn’s and Colitis panel
“Crohn’s disease and Colitis collectively are inflammatory bowel diseases (IBD). These inflammatory diseases impact the gastrointestinal tract (although not exclusively gastrointestinal tract). Most of these diseases can have an autoimmune component, particularly Crohn’s disease. Crohn’s disease can affect any part of the gastrointestinal tract anywhere from the mouth to the
Looking under the hood of the microbiome – functional insights through CAZyme analysis
Carbohydrate active enzymes (CAZymes) are responsible for modification of all carbohydrates, through both anabolic and catabolic pathways. Composed of five major classes and over 300 families and subfamilies, CAZymes play a role in all carbohydrate biochemistry and are vital for the well-being of many organisms. Plant pathogens like the white-rot fungus Dichomitus squalens, for example, require a repertoire of CAZymes to invade plant cells by breaking down the cell wall¹. In humans, the gut microbiome utilizes CAZymes to breakdown complex
Behind the Data with Dr. Tonya Ward
Drawing meaningful conclusions from microbiome experiments requires certainty in the experimental design and subsequent analysis; appropriate statistical descriptions of the microbiome are still an emerging area of inquiry. Dr. Tonya Ward, Diversigen’s Director of Data Science & Bioinformatics has worked throughout her career to identify methods to better characterize the
DNa Genotek's Podcast & Blogs
Diversigen’s sister company DNA Genotek offers new insights on microbiome, DNA and RNA sample collection, stabilization and services, through their blogs and podcast.
The Microbiome Snapshot
DNA Genotek’s Microbiome Blog
Molecules, Microbes and Multiomics
DNA Genotek’s Podcast
The information presented in these blogs and podcasts is made available for general information purposes and may include content provided by third parties. We do not warrant the accuracy, completeness, or usefulness of this information and disclaim all liability arising from reliance on it. The statements and opinions expressed in these materials, other than the content provided by us, are solely those of the person or entity making the statements.
Discover where our services can take you.
Diversigen provides services and generates data for research purposes only. Not all services are available in all regions.
